Why Sesen Bio's Stock Is Trading Higher Today
Sesen Bio Inc (NASDAQ: SESN) is rebounding higher Tuesday after the stock sold off Monday following the announcement that the U.S. Food and Drug Administration issued a Complete Response Letter for the company's bladder cancer candidate Vicineum.
